pharmaglobenews, Author at Pharma Globenewswire

Psoriatic Arthritis Therapeutics Market Size (7MM) projected to grow at significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology, as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom),

25 May 2026

Uncategorised

Wet Age-Related Macular Degeneration Market: Global Trends, Epidemiology, Emerging Therapies, and Growth Forecast Across the 7MM Through 2036

The Wet Age-Related Macular Degeneration market continues to demonstrate robust expansion across major markets worldwide. In 2023, the market size of Wet Age-Related Macular Degeneration (Wet AMD) was highest in the US among the 7MM, accounting for approximately USD 2,599 million, which

25 May 2026

Uncategorised

Inflammatory Bowel Disease Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2036, estimates DelveInsight

DelveInsight’s “Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Inflammatory Bowel Disease, historical and forecasted epidemiology as well as the Inflammatory Bowel Disease market trends in the United States, EU4 (Germany, France, Italy, and

22 May 2026

Uncategorised

Crohn’s Disease Market Set for Significant Growth: Rising Prevalence, Biologic Innovations, and Emerging Therapies Drive Expansion Through 2034

The Crohn’s Disease market is experiencing robust expansion across the 7 Major Markets (7MM). The market size is expected to grow from USD 11,367 million in 2025 to USD 16,840 million in 2034, reflecting a CAGR of 4.40%. This steady growth is

22 May 2026

Market Insights·News·Reports

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

Infusion Pumps Companies are B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Medtronic plc., Fresenius Kabi, CareFusion Corporation, Smiths Medical, Koninklijke Philips NV, Micrel Medical Devices SA, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Johnson

21 May 2026

Clinical Trials·News·Reports

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

Alcohol Use Disorder (AUD) companies such as Adial Pharmaceuticals, Imbrium Therapeutics, BioCorRx Pharmaceuticals, Beckley Psytech, Cybin, BioXcel Therapeutics, MediciNova, and others are actively redefining the future of addiction therapeutics through innovative drug development strategies, precision medicine approaches, and expanding clinical pipelines. DelveInsight’s,

21 May 2026

Clinical Trials·News·Reports

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

Atopic Dermatitis companies such as Innocare Pharma, Apogee Therapeutics, Celldex Therapeutics, Aclaris Therapeutics, BioCryst Pharmaceuticals, Vanda Pharmaceuticals, and several others are actively reshaping the future of Atopic Dermatitis (AD) therapeutics through innovative drug development strategies, targeted immunological approaches, and a rapidly expanding

21 May 2026

Uncategorised

Big Data in Healthcare Market Expected to Witness Robust Growth by 2032 Across Global Markets | DelveInsight

The Big Data in Healthcare market is anticipated to grow at a substantial CAGR during the forecast period from 2025 to 2032 across key global regions, including North America, Europe, Asia-Pacific, and Rest of the World. The market growth is expected to

21 May 2026

Uncategorised

Exosomes Pipeline Insights 2026: Emerging Therapies, Clinical Advances, and Industry Leaders

DelveInsight’s “Exosomes Pipeline Insights 2026” Report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Exosomes pipeline landscape. It covers the Exosomes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes pipeline therapeutics assessment by

21 May 2026

Uncategorised

Pulmonary Arterial Hypertension Market Set for Robust Growth Driven by Innovative Therapies, Expanding Pipeline, and Rising Global Disease Burden Through 2036

According to DelveInsight’s analysis, the Pulmonary Arterial Hypertension market size was ~USD 8 billion in the leading markets (the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025. The market is poised for continued expansion

21 May 2026

pharmaglobenews

Psoriatic Arthritis Therapeutics Market Size (7MM) projected to grow at significant CAGR by 2034, estimates DelveInsight

Inflammatory Bowel Disease Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2036, estimates DelveInsight

Crohn’s Disease Market Set for Significant Growth: Rising Prevalence, Biologic Innovations, and Emerging Therapies Drive Expansion Through 2034

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

Big Data in Healthcare Market Expected to Witness Robust Growth by 2032 Across Global Markets | DelveInsight

Exosomes Pipeline Insights 2026: Emerging Therapies, Clinical Advances, and Industry Leaders

Pulmonary Arterial Hypertension Market Set for Robust Growth Driven by Innovative Therapies, Expanding Pipeline, and Rising Global Disease Burden Through 2036

Recent Posts

Banner

Newsletter

Authors